Showing results 9 to 12 of 12
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Inhibition of class I Histone Deacetylases (HDACs) by HDAC inhibitors leads to the induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-positive epithelial malignancies Proceeding/Conference:Hong Kong International Cancer Congress, HKICC 2014 | 2014 | 45 | ||
Inhibition of class I histone deacetylases (HDACs) by HDAC inhibitors leads to the induction of Epstein-Barr virus lytic cycle in EBV-positive epithelial malignancies Proceeding/Conference:International Symposium on EBV & Associated Diseases | 2014 | 36 | ||
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir Journal:International Journal of Cancer | 2016 | 147 | ||
Reactivation of Epstein-Barr virus by a dual-responsive fluorescent EBNA1-targeting agent with Zn2+-chelating function Journal:Proceedings of the National Academy of Sciences | 2019 | 32 |